These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11752097)

  • 1. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
    Rizzi D; Rizzi A; Bigoni R; Camarda V; Marzola G; Guerrini R; De Risi C; Regoli D; Calo' G
    J Pharmacol Exp Ther; 2002 Jan; 300(1):57-63. PubMed ID: 11752097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G; Rizzi A; Guerrini R; Barnes TA; McDonald J; Hebbes CP; Mela F; Kenigs VA; Marzola G; Rizzi D; Gavioli E; Zucchini S; Regoli D; Morari M; Salvadori S; Rowbotham DJ; Lambert DG; Kapusta DR; Calo' G
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1114-23. PubMed ID: 15509719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist.
    Bigoni R; Calo' G; Rizzi A; Guerrini R; De Risi C; Hashimoto Y; Hashiba E; Lambert DG; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):565-8. PubMed ID: 10832612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
    Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G
    Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G; Morari M; Lambert DG; Regoli D; Calò G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):961-7. PubMed ID: 17329552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues.
    Rizzi D; Bigoni R; Rizzi A; Jenck F; Wichmann J; Guerrini R; Regoli D; Calo G
    Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):551-5. PubMed ID: 11383716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
    J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice.
    Rizzi A; Rizzi D; Marzola G; Regoli D; Larsen BD; Petersen JS; Calo' G
    Br J Pharmacol; 2002 Oct; 137(3):369-74. PubMed ID: 12237257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist.
    Calo' G; Guerrini R; Bigoni R; Rizzi A; Marzola G; Okawa H; Bianchi C; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2000 Mar; 129(6):1183-93. PubMed ID: 10725267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors.
    Bigoni R; Rizzi A; Rizzi D; Becker JA; Kieffer BL; Simonin F; Regoli D; Calo G
    Life Sci; 2000 Dec; 68(2):233-9. PubMed ID: 11191640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.
    Flau K; Redmer A; Liedtke S; Kathmann M; Schlicker E
    Br J Pharmacol; 2002 Dec; 137(8):1355-61. PubMed ID: 12466246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung.
    Corboz MR; Rivelli MA; Egan RW; Tulshian D; Matasi J; Fawzi AB; Benbow L; Smith-Torhan A; Zhang H; Hey JA
    Eur J Pharmacol; 2000 Aug; 402(1-2):171-9. PubMed ID: 10940371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of nociceptin receptor: an in vitro study.
    Calò G; Rizzi A; Bodin M; Neugebauer W; Salvadori S; Guerrini R; Bianchi C; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):713-8. PubMed ID: 9276153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors.
    Bigoni R; Caò G; Rizzi A; Okawa H; Regoli D; Smart D; Lambert DG
    Can J Physiol Pharmacol; 2002 May; 80(5):407-12. PubMed ID: 12056546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
    Peng YL; Chang M; Dong SL; Li W; Han RW; Fu GX; Chen Q; Wang R
    Regul Pept; 2006 May; 134(2-3):75-81. PubMed ID: 16516988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated.
    Ichikawa D; Ozaki S; Azuma T; Nambu H; Kawamoto H; Iwasawa Y; Takeshima H; Ohta H
    Neuroreport; 2001 Jun; 12(8):1757-61. PubMed ID: 11409754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions.
    Broccardo M; Linari G; Guerrini R; Agostini S; Petrella C; Improta G
    Peptides; 2005 Sep; 26(9):1590-7. PubMed ID: 16112397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies.
    Bigoni R; Rizzi D; Rizzi A; Camarda V; Guerrini R; Lambert DG; Hashiba E; Berger H; Salvadori S; Regoli D; Calo' G
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):442-9. PubMed ID: 12070757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study.
    Linari G; Agostini S; Broccardo M; Petrella C; Improta G
    Pharmacol Res; 2006 Nov; 54(5):356-60. PubMed ID: 16979347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.